Baylor Research Institute

Dallas, Texas 75246-2079

6 studies enrolling now · 88 studies all time

What they study most

Acne Vulgaris, Acute Kidney Injury, Acute Myelogenous Leukemia, Acute Myelogenous Leukemia in Relapse, Acute Myelogenous Leukemia, Adult, Acute Myelogenous Leukemia, Relapsed, Adult, Acute Myeloid Leukemia, Acute Myocardial Infarction, Advanced Malignancies, Advanced Refractory Left Ventricular Heart Failure, African Americans, Alzheimer Disease

Studies at this site

• A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies — Recruiting now
• Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance — Recruiting now
• The Fourth Left Atrial Appendage Occlusion Study — Recruiting now
• [18F]PI-2620 Phase 3 Histopathological Study — Recruiting now
• Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease — Recruiting now
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies — Completed
• Surveillance HeartCare® Outcomes Registry — Running, not enrolling
• A Study of Surgical Interventions in Fistulizing Conditions — Completed
• Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension — Running, not enrolling
• A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme — Running, not enrolling
• Genetic Testing to Understand and Address Renal Disease Disparities Across the United States — Completed
• Long-Term Follow-up Study — Enrolling by invitation
• Giving a Low Carbohydrate Diet to Overcome Hypertension — Completed
• The Integrated Population (I-POP) Health Trial — Completed
• Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment — Completed
• Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients — Stopped early
• MMRF Molecular Profiling Protocol — Status unconfirmed
• STOP Persistent AF — Completed
• Randomized On-X Anticoagulation Trial — Completed
• Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling — Completed
• Phase 3 Randomized, Open-Label Study of Guadecitabine vs Treatment Choice in Previously Treated Acute Myeloid Leukemia — Completed
• Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With Psoriasis — Completed
• Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis — Completed
• Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile — Completed
• PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine) — Completed
• An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma — Completed
• Characterization & Treatment of Chronic Pain After Moderate to Severe TBI — Completed
• An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus — Completed
• Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis — Stopped early
• A Study of APTO-253 in Patients With Relapsed or Refractory AML or MDS — Stopped early
• Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis — Completed
• MOMENTUM 3 IDE Clinical Study Protocol — Completed
• MOMENTUM 3 Continued Access Protocol — Completed
• Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer — Status unconfirmed
• Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation — Completed
• Mylan Insulin Aspart Study — Completed
• A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL) — Completed
• Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis — Completed
• A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Still's Disease (SJIA and AOSD) — Stopped early
• Data Collection Registry of the HeRO Graft for End Stage Renal Disease Patients Receiving Hemodialysis — Withdrawn before enrolling
• CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer — Status unconfirmed
• Model 4396 Left Ventricular (LV) Lead Chronic Performance Study — Completed
• Study to Evaluate Efficacy and Safety of E-101 Solution for Preventing Surgical Site Infections After Colorectal Surgery — Completed
• Reducing Chronic Kidney Disease Burden in an Underserved Population — Completed
• National Marrow Donor Program Long-Term Donor Follow-Up — Completed
• Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer — Completed
• Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer — Completed
• Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis — Completed